• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 管理在耐用型左心室辅助装置受者中的应用:持续护理视角。

Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective.

机构信息

Department of Internal Medicine, The Ohio State University, Columbus, OH, United States.

Division of Cardiovascular Medicine, The Ohio State University, Columbus, OH, United States.

出版信息

Heart Lung. 2020 Nov-Dec;49(6):688-691. doi: 10.1016/j.hrtlng.2020.08.012. Epub 2020 Aug 20.

DOI:10.1016/j.hrtlng.2020.08.012
PMID:32861886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7440278/
Abstract

COVID-19 is impacting the cardiovascular community both here in the United States and globally. The rapidly emerging cardiac complications have heightened implications for those with underlying cardiovascular disease. We describe an early case of COVID-19 in a left ventricular assist device recipient in the United States. We discuss our clinical management during the initial admission, outpatient management, and a unique complication of this disease over a 40-day disease course.

摘要

COVID-19 正在影响美国和全球的心血管界。迅速出现的心脏并发症对那些患有潜在心血管疾病的人产生了更深远的影响。我们在美国报告了一例左心室辅助装置接受者的 COVID-19 早期病例。我们讨论了在初始入院期间、门诊管理期间以及在 40 天的疾病过程中该疾病的独特并发症的临床管理。

相似文献

1
Management of COVID-19 in a durable left ventricular assist device recipient: A continuity of care perspective.COVID-19 管理在耐用型左心室辅助装置受者中的应用:持续护理视角。
Heart Lung. 2020 Nov-Dec;49(6):688-691. doi: 10.1016/j.hrtlng.2020.08.012. Epub 2020 Aug 20.
2
Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support.一名接受长期左心室辅助装置支持的患者感染2019年新型冠状病毒病
J Card Fail. 2020 May;26(5):438-439. doi: 10.1016/j.cardfail.2020.04.007. Epub 2020 Apr 17.
3
[Issues and challenges related to COVID-19 in acute geriatric care: lessons learned from the Geneva experience].[急性老年护理中与新型冠状病毒肺炎相关的问题和挑战:从日内瓦经验中吸取的教训]
Rev Med Suisse. 2020 Nov 11;16(714):2153-2155.
4
Rapid Deterioration of Hospital-Acquired COVID-19 in a Patient on Extracorporeal Left Ventricular Assist Support.体外左心室辅助支持患者的 COVID-19 院内快速恶化。
Heart Lung. 2020 Nov-Dec;49(6):808-811. doi: 10.1016/j.hrtlng.2020.08.021. Epub 2020 Sep 21.
5
[COVID-19: A neurological point-of-view].[新型冠状病毒肺炎:神经学视角]
Dtsch Med Wochenschr. 2020 Jul;145(15):1074-1079. doi: 10.1055/a-1164-4323. Epub 2020 Jul 30.
6
Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports.2019冠状病毒病患者在左心室辅助装置支持期间的治疗策略
J Card Fail. 2020 Jun;26(6):479. doi: 10.1016/j.cardfail.2020.04.014. Epub 2020 May 1.
7
Short-term Outcomes in Ambulatory Heart Failure during the COVID-19 Pandemic: Insights from Pulmonary Artery Pressure Monitoring.COVID-19大流行期间门诊心力衰竭的短期结局:来自肺动脉压力监测的见解
J Card Fail. 2020 Jul;26(7):633-634. doi: 10.1016/j.cardfail.2020.05.021. Epub 2020 Jun 4.
8
Characteristics and Outcomes of Patients With a Left Ventricular Assist Device With Coronavirus Disease-19.植入左心室辅助装置的新型冠状病毒肺炎患者的特征与预后
J Card Fail. 2020 Oct;26(10):895-897. doi: 10.1016/j.cardfail.2020.09.011. Epub 2020 Sep 19.
9
The Early Natural History of SARS-CoV-2 Infection: Clinical Observations From an Urban, Ambulatory COVID-19 Clinic.新型冠状病毒2型感染的早期自然史:来自一家城市门诊COVID-19诊所的临床观察
Mayo Clin Proc. 2020 Jun;95(6):1124-1126. doi: 10.1016/j.mayocp.2020.04.010. Epub 2020 Apr 20.
10
Introduction: Finding a way in daily clinical practice during COVID-19 pandemic.引言:在新冠疫情期间的日常临床实践中寻找方法。
Eur J Clin Invest. 2020 Jul;50(7):e13329. doi: 10.1111/eci.13329.

引用本文的文献

1
Comparison of the course of SARS-CoV-2 infection in left ventricular assist device recipients implanted before and during COVID-19 pandemic.COVID-19大流行之前和期间植入左心室辅助装置的患者中新型冠状病毒2型感染病程的比较。
Cardiol J. 2023;30(4):668-670. doi: 10.5603/CJ.a2023.0044. Epub 2023 Jul 4.
2
Heart failure in COVID-19 patients: Critical care experience.新型冠状病毒肺炎患者的心力衰竭:重症监护经验
World J Virol. 2022 Jan 25;11(1):1-19. doi: 10.5501/wjv.v11.i1.1.
3
Management of Patients with Left Ventricular Assist Device during the COVID-19 Pandemic.

本文引用的文献

1
Predisposition or Protection?: COVID-19 in a Patient on LVAD Support With HIV/AIDS.易感性还是保护性?:一名接受左心室辅助装置支持且感染艾滋病毒/艾滋病的患者的新冠肺炎情况
JACC Case Rep. 2020 Jul 15;2(9):1337-1341. doi: 10.1016/j.jaccas.2020.05.015. Epub 2020 May 19.
2
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.17例长期接受羟氯喹治疗的系统性红斑狼疮患者的2019冠状病毒病(COVID-19)临床病程
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
3
Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support.
COVID-19 大流行期间左心室辅助装置患者的管理。
Medicina (Kaunas). 2022 Jan 13;58(1):116. doi: 10.3390/medicina58010116.
4
COVID-19 complicating perioperative management of LVAD implantation: A case report and systematic review.COVID-19 使 LVAD 植入术围手术期管理复杂化:病例报告和系统评价。
J Card Surg. 2021 Sep;36(9):3405-3409. doi: 10.1111/jocs.15690. Epub 2021 Jun 6.
一名接受长期左心室辅助装置支持的患者感染2019年新型冠状病毒病
J Card Fail. 2020 May;26(5):438-439. doi: 10.1016/j.cardfail.2020.04.007. Epub 2020 Apr 17.
4
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.住院 COVID-19 合并高血压患者中血管紧张素转换酶抑制剂和血管紧张素 II 受体阻滞剂的住院使用率与死亡率的关系。
Circ Res. 2020 Jun 5;126(12):1671-1681. doi: 10.1161/CIRCRESAHA.120.317134. Epub 2020 Apr 17.
5
The Imperfect Cytokine Storm: Severe COVID-19 With ARDS in a Patient on Durable LVAD Support.不完美的细胞因子风暴:一名接受长期左心室辅助装置支持的患者发生伴有急性呼吸窘迫综合征的重症新冠肺炎
JACC Case Rep. 2020 Jul 15;2(9):1315-1320. doi: 10.1016/j.jaccas.2020.04.001. Epub 2020 Apr 8.
6
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.药物治疗 2019 冠状病毒病(COVID-19):综述。
JAMA. 2020 May 12;323(18):1824-1836. doi: 10.1001/jama.2020.6019.
7
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
8
Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin.糖皮质激素联合人免疫球蛋白治疗冠状病毒暴发性心肌炎
Eur Heart J. 2021 Jan 7;42(2):206. doi: 10.1093/eurheartj/ehaa190.
9
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素:一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
10
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.